Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

CROs in a Global State of Mind

February 1, 2013

Pharmaceutical Technology

CROs are keeping pace with the increased globalization of the biopharmaceutical/pharmaceutical industry through a combination of acquisitions, partnerships, and select investments.

The State of Outsourcing Partnerships

February 1, 2013

Pharmaceutical Technology

Preferred-provider relationships are transforming the bio/pharmaceutical industry.

Seeking Strength in Partnership Strategies

February 1, 2013

Pharmaceutical Technology

In the arena of pharmaceutical outsourcing, when speaking of partnerships, the discussion typically focuses on the relationship between a pharmaceutical/biopharmaceutical company as the sponsor company and a contract-service provider.

The Future of BioPharma

February 1, 2013

Pharmaceutical Technology

Innovation resulting in improved productivity continues unabated and is a primary driver for many of the current biopharmaceutical trends.

Offshoring Biomanufacturing

January 1, 2013

Pharmaceutical Technology

Will international biomanufacturing outsourcing become mainstream in this decade?

Acquisitions Reshape the Bio/Pharm Services Industry

December 2, 2012

Pharmaceutical Technology

The quest to build critical mass and broaden capabilities has been a key factor in deal-making.

Designing a Clean-in-Place System

November 21, 2012

Equipment and Processing Report

An efficient cleaning cycle begins with equipment and automation-system design.

Advice for Enhancing the Client–Sponsor Relationship

November 2, 2012

Pharmaceutical Technology

Key talks from the recent PDA/FDA regulatory conference highlight room for improvement.

Creating a Holistic Procurement System

November 2, 2012

Pharmaceutical Technology

The procurement organization rethinks sourcing for maximum efficiency and results.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here